Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Nestle plans to launch a frozen-food brand Vital Pursuit aimed at consumers who are taking Ozempic and Wegovy.
Over the last year, the buzzy weight loss and diabetes drugs have taken off as more options hit the market and celebrities like Oprah Winfrey andfrom health policy research organization KFF. Roughly half of those Americans, or around 6% of U.S. adults, are currently using one of the treatments. The total number of U.S. consumers taking the medication could soar to 31.
sandwich melts and pizzas. The products will include one or more essential nutrients, like protein, calcium or iron. The company plans to sell Vital Pursuit items for $4.99 or under and offer gluten-free options.
Restaurants Business Breaking News: Business United States Nestle SA Nestle SA Walmart Inc Elon Musk Business News
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Denmark to Restrict Ozempic, Other GLP-1 Drugs, to Treat Type 2 DiabetesDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...
Read more »
Mom Loses 65 Lbs With GLP-1, Counting Macros, Strength TrainingStephanie Thurrott is a writer who covers mental health, personal growth, wellness, family, food and personal finance, and dabbles in just about any other topic that grabs her attention. When she's not writing, look for her out walking her dog or riding her bike in Pennsylvania's Lehigh Valley.
Read more »
No, GLP-1 Supplements *Are Not* the Same as Prescription Drugs Like OzempicLearn how GLP-1 weight loss medications like Wegovy work in the body and whether over-the-counter GLP-1 supplements are as effective.
Read more »
GLP-1 Receptor Agonists Before Endoscopy: AGA Issues Rapid Clinical Practice UpdateThe update included background on the relationship between GLP-1 receptor agonists and endoscopic procedures, followed by clinical strategies for patients taking these medications.
Read more »
Counseling Patients Who Want to Try a GLP-1 RAPrimary care physicians are getting a lot of questions about these new weight loss agents. What concerns should be prioritized during a brief visit?
Read more »
Low Aspiration Risk in Adults on GLP-1s Undergoing Upper EndoscopyA retrospective study reported a 0.1% aspiration rate in adults taking GLP-1 receptor agonists and undergoing esophagogastroduodenoscopy, despite a 9.4% rate of retained gastric contents.
Read more »